Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
ANTX on Nasdaq
There are no Buy or Sell transactions made by Adjuvant Global Health Technology Fund, L.P. since 12 Mar 2025
Holdings reported by Adjuvant Global Health Technology Fund, L.P. for AN2 Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,995,958 |
$38,150,941 |
$19.11 |
16 Jan 2024 |
Direct |
|
|
| Common Stock |
377,542 |
$7,216,376 |
$19.11 |
16 Jan 2024 |
By Adjuvant Global Health Technology Fund DE, L.P. |
|
|
Transactions reported by Adjuvant Global Health Technology Fund, L.P. for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.